Author

Eduardo Galaricha

Institut National de la Sante et de la Recherche Medicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, Toulouse, France; Universite de Toulouse, Toulouse, France;

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aline Mairal· 1 shared Arnaud Del Bello· 1 shared Arthur Thomas· 1 shared Emma Ballongue· 1 shared Fabrice Raynaud· 1 shared Guylene Feuillet· 1 shared Jonas Laguet· 1 shared Joost Peter SchanstraiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Aline Mairal

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PathologybioRxivPreprintNov 6, 2026

Systematic comparison of gliflozins identifies a selective anti-calcifying effect of canagliflozin beyond canonical SGLT2 inhibition

Lucie Fernandez, Manon Brunet, Emma Ballongue…·Julie Klein

This study compares gliflozins and finds canagliflozin uniquely reduces vascular calcification through mechanisms beyond SGLT2 inhibition, affecting VSMC metabolism and calcification.

DOI 10.64898/2026.11.05.764503

mousebulk RNA-seq

𝕏 PostBluesky